ATP9BL2, also known as ATPase Phospholipid Transporting 9B Like 2, is a protein that is believed to belong to the P4-ATPase subfamily of phospholipid-transporting ATPases. These proteins are integral membrane proteins that are specialized in flipping phospholipids from the outer to the inner leaflet of cellular membranes, a process critical to maintaining the asymmetric distribution of phospholipids in the lipid bilayer.
The specific function of ATP9BL2 is not as well-characterized as other members of the P4-ATPase family, but by analogy, it is likely involved in cellular processes that depend on membrane lipid composition and asymmetry. Such processes include vesicle formation, cell division, and the maintenance of membrane integrity. The translocation of specific phospholipids to the cytoplasmic side of the bilayer by ATP9BL2 could be essential for creating membrane curvature, which facilitates vesicle budding and fusion events necessary for intracellular trafficking.ATP9BL2 may possess a structure typical of P-type ATPases, with a catalytic domain that binds and hydrolyzes ATP, transmembrane domains that form the substrate translocation pathway, and regulatory regions that modulate the enzyme's activity. Phosphorylation and dephosphorylation events are central to the transport mechanism, involving the formation of a phosphorylated enzyme intermediate.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin could indirectly affect ATP9BL2 by enhancing cAMP levels, which can influence various ATPases. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $106.00 $166.00 $289.00 $550.00 $819.00 | 2 | |
8-Br-cAMP, a cAMP analog, may indirectly activate ATP9BL2 by mimicking cAMP's cellular effects. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Isobutylmethylxanthine (IBMX) can indirectly impact ATP9BL2 activity by increasing intracellular cAMP. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $90.00 $350.00 | 16 | |
Cilostamide raises cAMP levels, potentially influencing ATP9BL2 activity indirectly. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram enhances cAMP levels, which might indirectly affect ATP9BL2. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $162.00 $683.00 | 7 | |
By inhibiting phosphodiesterase-3, Milrinone can indirectly activate ATP9BL2 through increased cAMP. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Epinephrine, through adenylyl cyclase activation, could indirectly influence ATP9BL2 via increased cAMP. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol raises cAMP levels, potentially impacting ATP9BL2 activity indirectly. | ||||||
Dobutamine | 34368-04-2 | sc-507555 | 100 mg | $295.00 | ||
Dobutamine, via β-adrenergic receptor activation, may raise cAMP levels, indirectly affecting ATP9BL2. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $90.00 $371.00 | 2 | |
Terbutaline, a β2-adrenergic receptor agonist, raises cAMP levels, potentially influencing ATP9BL2 indirectly. | ||||||